SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-23-043094
Filing Date
2023-11-29
Accepted
2023-11-29 17:15:27
Documents
63
Period of Report
2023-09-30
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k-a.htm   iXBRL 8-K/A 66586
2 ex99-3.htm   iXBRL EX-99.3 641214
  Complete submission text file 0001493152-23-043094.txt   4544551

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ntbl-20230930.xsd EX-101.SCH 37957
4 XBRL CALCULATION FILE ntbl-20230930_cal.xml EX-101.CAL 51653
5 XBRL DEFINITION FILE ntbl-20230930_def.xml EX-101.DEF 313219
6 XBRL LABEL FILE ntbl-20230930_lab.xml EX-101.LAB 273599
7 XBRL PRESENTATION FILE ntbl-20230930_pre.xml EX-101.PRE 320228
57 EXTRACTED XBRL INSTANCE DOCUMENT form8k-a_htm.xml XML 631014
Mailing Address 320 HATCH DRIVE FOSTER CITY CA 94404
Business Address 320 HATCH DRIVE FOSTER CITY CA 94404 415-851-2410
Notable Labs, Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36581 | Film No.: 231453288
SIC: 2834 Pharmaceutical Preparations